Search results
Is This Vertex Pharmaceuticals' Biggest News Yet?
Motley Fool· 2 years agoIt's been a big year for Vertex Pharmaceuticals (NASDAQ: VRTX) so far. The biotech company has grown its main cystic fibrosis (CF) business -- reporting...
Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) is the global leader in cystic fibrosis (CF) treatment. The...
Vertex Pharmaceuticals: Buy at the High?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) has a lot going on these days. The biotech company is developing two candidates that could make it even stronger in...
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 4 weeks agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Is Vertex Pharmaceuticals Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has been one of the hottest growth stocks to own within the healthcare industry. The company has a dominant cystic...
This FDA Nod Is a Game Changer for Patients: Could It Equal Billions for Vertex Pharmaceuticals?
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) is already a rock star in the world of cystic fibrosis (CF)...
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) and AbbVie (NYSE: ABBV) both beat last year's bear market....
2 Green Flags for Vertex Pharmaceuticals' Future
Motley Fool· 2 years agoBiotech Vertex Pharmaceuticals (NASDAQ: VRTX) is defying the stock market sell-off this year. While that's great news for shareholders, it's essential to...
This Growth Stock Crushed the Market Last Year. 5 Words from the CEO Suggest There's More to Come.
Motley Fool· 1 year agoVertex Pharmaceuticals (NASDAQ: VRTX) stock climbed more than 31% last year even as the overall...
Vertex Pharmaceuticals Stock Gets Technical Rating Upgrade
Investor's Business Daily· 1 year agoVertex Pharmaceuticals stock saw a positive improvement to its Relative Strength (RS) Rating on...
